The year 2025 was special for us – the first year in which we began building DOX PHARM and turning our vision into reality.
In just 12 months, we succeeded in laying strong foundations:
New products – we developed and launched our first formulations, which were quickly recognized and positively received by the market.
Market positioning – we secured our place among relevant pharmaceutical companies and opened the door to future growth.
Internationalization – already in our first year, we established companies abroad, as we have thought globally from the very beginning.
Scientific research – we invested in projects that will contribute in the long term to innovation and the advancement of higher-quality healthcare. We are especially proud of our fully innovative VERDE BIOTIC technology.
This first year has proven that vision, dedication, and teamwork can deliver results even in the early stages of business development. I am grateful to my colleagues within the company, as well as to our partners and associates, for their trust and support. We are entering 2026 with even greater ambitions – ready to grow, innovate, and build a healthier future.
We look forward to the new challenges and opportunities that 2026 will bring – together, we are building a healthier future!
Chief Executive Officer
Prof. Dr. Davor J. Korčok
